Form D · REITS and Finance
CF Life Sciences REIT LLC
Dallas, TX · CIK 0001959347
Offering snapshot reported Dec 21, 2022 · SEC filing
- Reported sold
- $125K Offering amount: $125K
- Investors reported
- 124 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- Dec 8, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 21, 2022 | Initial | $125,000 | No comparison | 124 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $6.25K
- Finders' fees
- $0
- Form D file number
- 021-468233
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Charles B. Harrison | 3071551 | H & L Equities, LLC · CRD 113794 |
| Lori Mayfield | 4899271 | H & L Equities, LLC · CRD 113794 |
| Patrick J. Whelchel | 5389090 | H & L Equities, LLC · CRD 113794 |
| Scott Harrison | 4981070 | H & L Equities, LLC · CRD 113794 |
Source: Form D, filed Dec 21, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Russ Goin | Executive |
Issuer details
Industry: REITS and Finance (See others in industry)
Address:
2000 Mckinney Avenue, 12 Th Floor Suite 1220
Dallas, TX, 75201
Dallas, TX, 75201